Crestchem Limited
Crestchem Limited Fundamental Analysis
Crestchem Limited (CRSTCHM.BO) shows moderate financial fundamentals with a PE ratio of 10.51, profit margin of 8.30%, and ROE of 30.24%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 60.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze CRSTCHM.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentCRSTCHM.BO demonstrates superior asset utilization.
Valuation Score
ExcellentCRSTCHM.BO trades at attractive valuation levels.
Growth Score
ModerateCRSTCHM.BO shows steady but slowing expansion.
Financial Health Score
ModerateCRSTCHM.BO shows balanced financial health with some risks.
Profitability Score
WeakCRSTCHM.BO struggles to sustain strong margins.
Key Financial Metrics
Is CRSTCHM.BO Expensive or Cheap?
P/E Ratio
CRSTCHM.BO trades at 10.51 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CRSTCHM.BO's PEG of 1.09 indicates fair valuation.
Price to Book
The market values Crestchem Limited at 2.89 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.73 times EBITDA. This is generally considered low.
How Well Does CRSTCHM.BO Make Money?
Net Profit Margin
For every $100 in sales, Crestchem Limited keeps $8.30 as profit after all expenses.
Operating Margin
Core operations generate 11.05 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $30.24 in profit for every $100 of shareholder equity.
ROA
Crestchem Limited generates $16.39 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Crestchem Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Crestchem Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
CRSTCHM.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
10.51
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.89
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.87
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.44
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.30
vs 25 benchmark
ROA
Return on assets percentage
0.16
vs 25 benchmark
ROCE
Return on capital employed
0.36
vs 25 benchmark
How CRSTCHM.BO Stacks Against Its Sector Peers
| Metric | CRSTCHM.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 10.51 | 27.91 | Better (Cheaper) |
| ROE | 30.24% | 687.00% | Weak |
| Net Margin | 8.30% | -45285.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 0.44 | 2795.76 | Weak Liquidity |
| ROA | 16.39% | -13557.00% (disorted) | Strong |
CRSTCHM.BO outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Crestchem Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation